Lung cancer incidence rates in the United States have undergone a significant transformation over the last several decades, ...

The five-year survival rate for all cancers combined in the US reached a landmark 70% for Americans diagnosed between 2015 ...

An annual report from the American Cancer Society shows that, for the first time, over 70% of Americans diagnosed with cancer ...

Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal ...

TORONTO — Five-year survival rates for people with lung cancer have doubled since the 1990s, but the disease still kills more patients than any other type of cancer, a Statistics Canada report said on ...

– The First Pivotal Phase 3 Trial to Demonstrate Superiority of a TROP-2 Antibody-Drug Conjugate, Trodelvy, Plus Keytruda Versus Standard of Care Keytruda plus Chemotherapy in 1L mTNBC – – Trodelvy ...

Five-year exploratory follow-up analysis of KEYNOTE-671 continued to show clinically meaningful improvements in overall survival and event-free survival with KEYTRUDA plus chemotherapy before surgery, ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the chances of patients’ survival. The key? Detecting tiny lung nodules when doctors ...

Please provide your email address to receive an email when new articles are posted on . Five-year lung cancer survival has improved with increased screening, which has led to more early-stage ...

First and only systemic therapy to improve survival when used before and after surgery for patients with MIBC who are ineligible for cisplatin-based chemotherapy First ever positive Phase 3 study in ...